Sunday, September 24, 2023
Read Overview
Supported by independent educational grant from Chiesi USA
Supported by independent educational grant from CinCor Pharma
Supported by independent educational grant from Cytokinetics
Supported by independent educational grant from Merck & Co., Inc.
Supported by independent educational grant from Pfizer/Merck Alliance
Supported by independent educational grant from Regeneron
Co-Chair
Arthur L. Bloomfield
Professor of Medicine
Professor of Health Policy (by courtesy)
Chair, Department of Medicine
Stanford University School of Medicine
Palo Alto, California
Co-Chair
Assistant Professor of Medicine
Department of Cardiovascular Medicine
Stanford University School of Medicine
Palo Alto, California
Planning Committee Member
President, Baylor Scott and White Research Institute
Dallas, Texas
Distinguished Professor of Medicine
University of Mississippi
Jackson, Mississippi
Planning Committee Member
Professor, University of Manitoba
Director, St. Boniface Hospital Heart Failure and Transplant Clinics
Head, Medical Heart Failure Program, Cardiac Sciences Manitoba
Immediate Past President, Canadian Heart Failure Society
SPC Chair, Canadian Cardiovascular Congress
Manitoba, Canada
Planning Committee Member
Professor of Medicine, Cardiology
Director, Seinsheimer Cardiovascular Health Program
The Medical University of South Carolina
Charleston, South Carolina
Planning Committee Member
Director of Mount Sinai Heart
Dr Valentin Fuster Professor of Cardiovascular Medicine
New York, New York
Planning Committee Member
Chief, Division of Cardiology
Co-Director Duke Heart Center
Duke University
Durham, North Carolina
Planning Committee Member
Director of the Center for Women's Cardiovascular Health
Atrium Health Sanger Heart and Vascular Institute
Charlotte, North Carolina
Has disclosed the following relevant financial relationships:
Consultant or advisor for: 48 Inc; Aprotos; Element Science
Research funding from: Janssen
Stock options from: 48 Inc; Atropos; SignalPath
Ownership interest: 49 Inc; Atropos; SignalPath
Has disclosed the following relevant financial relationships:
Consultant or advisor for: Amgen (former); HealthPals; Novartis; Novo Nordisk
Ownership interest: Carta Healthcare; HealthPals
Has disclosed the following relevant financial relationships:
Consultant or advisor for: Abbott; Adrenomed; Amgen; Applied Therapeutics; Array; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol Myers Squibb Company; CVRx; G3 Pharma; Impulse Dynamics; Innolife; Janssen; LivaNova; Luitpold; Medtronic; Merck; Novartis; Novo Nordisk; Relypsa; Roche; Sequana Medical; Vifor Pharma
Speaker or member of speakers bureau for: AstraZeneca; Boehringer Ingelheim; Janssen; Lilly; Novartis
Has disclosed the following relevant financial relationships:
Consultant or advisor for: Abbott; Akcea; AstraZeneca; Amgen; Alnylam; Bayer; Boehringer Ingelheim; Lilly; Merck; Novartis; Novo Nordisk; Otsuka; Pfizer; Servier; Vifor Pharma
Speaker or member of speakers bureau for: Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; HLS Therapeutics; Janssen; Lilly; Novartis; Servier; Vifor Pharma
Research funding from: Novartis; Servier
Contracted researcher for: Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Eidos; Merck; Novartis
Has disclosed the following relevant financial relationships:
Consultant or advisor for: Amgen; Esperion
Contracted researcher for: Esperion
Has disclosed the following relevant financial relationships:
Research funding from: 89Bio; Abbott; Afimmune; Aker Biomarine; Amarin; Amgen; AstraZeneca; Bayer; Beren; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb Company; Cardax; CellProthera; Cereno Scientific; Chiesi; CSL Behring; Eisai; Ethicon; Faraday Pharmaceuticals; Ferring Pharmaceuticals; Forest Laboratories; Fractyl; Garmin; HLS Therapeutics; Idorsia; Ironwood; Ischemix; Janssen; Javelin; Lexicon; Lilly; Medtronic; Moderna; MyoKardia; NirvaMed; Novartis; Novo Nordisk; Owkin; Pfizer; PhaseBio; PLx Pharma; Recardio; Regeneron; Roche; Sanofi; Stasys; Synaptic; The Medicines Company
Has disclosed the following relevant financial relationships:
Consultant or advisor for: Bayer; Janssen; Novartis
Research funding from: Bayer; Heartflow; Janssen; Novartis
Has no relevant financial relationships.
